| Name | Utreloxastat |
|---|
| Description | Utreloxastat is a compound used for the research of the disorders including α-synucleinopathies, tauopathies, Amyotrophic lateral sclerosis (ALS), traumatic brain injury, and ischemic-reperfusion related injuries (patent WO2020081879A2, example A1)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C18H28O2 |
|---|---|
| Molecular Weight | 276.41 |